-
Vazyme went public on the star market of the Shanghai Stock Exchange under the stock code 688105.
-
COVID-19 Solutions with high detection sensitivity were developed by Vazyme professional team and certified by more and more regions from all over the world.
-
Several key projects of Vazyme Medical passed the External Quality Assessment (EQA) of the National Center for Clinical Laboratories with full marks.
-
Vazyme Medical Technology CO., LTD was established, which aimed to deploy IVD testing reagents and instruments.
-
The International Business Department was set up with the belief of becoming the professional supplier of In Vitro Diagnostic Solutions worldwide.
-
Vazyme was established including a number of biomolecular research reagent product lines with independent intellectual property rights
English
简体中文